Brief: Neurizon Therapeutics Announces Placement Of Entitlement Offer Shortfall To Raise ~A$2.7 Million
16/04/2026 02:42
April 16 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX: ANNOUNCES PLACEMENT OF ENTITLEMENT OFFER SHORTFALL TO RAISE ~A$2.7 MILLION TOTAL AMOUNT TO BE RAISED UNDER ENTITLEMENT OFFER IS ~A$8.5 MILLION Further company coverage: NUZ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility